Analyst Research

Report Title Price
Provider: Stock Traders Daily
Provider: S&P Capital IQ Quantitative Report
Provider: S&P Capital IQ Quantitative Report
Provider: Pechala's Reports

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Bio-Rad Laboratories Inc Issues FY 2013 Revenue Guidance Above Analysts' Estimates-Conference Call

Tuesday, 26 Feb 2013 10:00pm EST 

Bio-Rad Laboratories Inc announced that for fiscal 2013, it expects currency neutral sales growth to be in the 3% to 3.5%. The Company reported revenue of $2.069 billion in fiscal 2012. According to I/B/E/S Estimates, analysts are expecting the Company to report revenue of $2.12 billion for fiscal 2013. 

Company Quote

-0.95 -0.80%
12 Sep 2014